Probiotix Health (FRA:X90) Quality Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:X90 Probiotix Health PLC FRA:X90
35 GF Score
Price €0.09
GF Value €0.08
! 4 Warning Signs
View Full Analysis

What is Probiotix Health Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Probiotix Health Quality Rank Related Terms

FRA:X90
35GF Score
Probiotix Health PLC FRA:X90
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Probiotix Health (FRA:X90) Overvalued in 2026?

Based on GuruFocus' analysis, Probiotix Health stock appears to be overvalued. The current stock price of €0.09 is trading 11.3% above its estimated GF Value™ of €0.08.

Key valuation signals for FRA:X90:

  • Quality Rank:
  • GF Value™: €0.08 vs. price of €0.09 (11.3% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the FRA:X90 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Probiotix Health Business Description

Other Exchanges PBX:UK
Address Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
35GF Score

Get the complete analysis for FRA:X90

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.08
GF Value